Class II · Moderate risk
Chlorthalidone Tablets
Failed Dissolution Specifications
Chlorthalidone Tablets
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Failed Dissolution Specifications
Cause type: Dissolution failure
The tablet or capsule did not dissolve within specification. Dissolution controls how much drug the body absorbs; a failure can change the effective dose. All dissolution failure recalls.
What was recalled
Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, Rx only, Manufactured by: Inventia Healthcare Limited, Additional Ambernath, M.I.D.C., Ambernath (East) - 421506, INDIA. Distributed by: Risiong Pharma Holdings, Inc., East Brunswick, NJ 08816. NDC 100-tablet bottle: 64980-599-01; NDC 1000-tablet bottle: 64980-599-10
Affected NDCs
64980-0599-01
64980-0599-10
Compare with the code on your package — it is the most precise check available.
Drug: Chlorthalidone
Product details
From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.
| Product | Strength | Form & route | Labeler | Type |
|---|---|---|---|---|
| Chlorthalidone NDC 64980-0599 |
25 mg/1 | Tablet Oral |
Rising Pharma Holdings, Inc. | Rx |
- Recalling firm
- Inventia Healthcare Limited
- Origin
- India
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-0610-2026 · FDA notice
Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.
Other Chlorthalidone recalls
See all
Class II · Moderate risk
Chlorthalidone Tablets
Failed Dissolution Specifications
Class II · Moderate risk
Chlorthalidone Tablets USP 25 mg
Foreign Matter identified as stainless steel microscopic wear particles mixed with punch lubricant oil and silicone particles from the dust cup
Class II · Moderate risk
CHLORTHALIDONE Tablets
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II · Moderate risk
edarbyclor Azilsartan Medoxomil and Chlorthalidone Tablets 40…
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Other recalls by Inventia Healthcare Limited
All 2026 recalls
Class II · Moderate risk
Chlorthalidone Tablets
Failed Dissolution Specifications
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.